Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis

Abu-Id, 2008, “Bis-phossy jaws”—high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw, J Craniomaxillofac Surg, 36, 95, 10.1016/j.jcms.2007.06.008 Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007: 65: 369–376. Assael, 2009, Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks and preventive strategies, J Oral Maxillofac Surg, 67, 35, 10.1016/j.joms.2009.01.003 Capsoni, 2006, Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role, Arthritis Res Ther, 8, 219, 10.1186/ar2050 Chen, 2008, Low-energy laser irradiation increases endothelial cell proliferation, migration, and eNOS gene expression possibly via PI3K signal pathway, Lasers Surg Med, 40, 46, 10.1002/lsm.20589 Corazza, 2007, Photobiomodulation on the angiogenesis of skin wounds in rats using different light sources, Photomed Laser Surg, 25, 102, 10.1089/pho.2006.2011 da Silva, 2010, Laser therapy in the tissue repair process: a literature review, Photomed Laser Surg, 28, 17, 10.1089/pho.2008.2372 Favia, 2009, Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinico-pathological features of 24 patients, J Rheumatol, 36, 2780, 10.3899/jrheum.090455 Felsenberg, 2006, Onkologie: Kiefernekrosen nach hoch dosierter bisphosphonatat thereapie, Dtsch rztebl, 103, A Hoff, 2008, Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates, J Bone Miner Res, 23, 826, 10.1359/jbmr.080205 Iwamoto, 2006, Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis, Curr Med Res Opin, 22, 919, 10.1185/030079906X100276 Khosla, 2007, Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research, J Bone Miner Res, 2, 1479, 10.1359/jbmr.0707onj Lo, 2010, Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure, J Oral Maxillofac Surg, 68, 243, 10.1016/j.joms.2009.03.050 Marx, 2003, Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic, J Oral Maxillofac Surg, 61, 1115, 10.1016/S0278-2391(03)00720-1 Marx, 2007, Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment, J Oral Maxillofac Surg, 65, 2397, 10.1016/j.joms.2007.08.003 Mavrokokki, 2007, Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia, J Oral Maxillofac Surg, 65, 415, 10.1016/j.joms.2006.10.061 Merigo, 2005, Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report, J Oral Pathol Med, 34, 613, 10.1111/j.1600-0714.2005.00351.x Murad, 2007, Bisphosphonates and osteonecrosis of the jaw: a retrospective study, Endocr Pract, 13, 232, 10.4158/EP.13.3.232 Pazianas, 2007, A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics, Clin Ther, 29, 1548, 10.1016/j.clinthera.2007.08.008 Rizzoli, 2008, Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis, Bone, 42, 841, 10.1016/j.bone.2008.01.003 Rodrigo, 2009, Analysis of the systemic effect of red and infrared laser therapy on wound repair, Photomed Laser Surg, 27, 929, 10.1089/pho.2008.2306 Ruggiero, 2009, American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update, J Oral Maxillofac Surg, 67, 2 Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004 Sedghizadeh, 2009, Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry, J Am Dent Assoc, 140, 61, 10.14219/jada.archive.2009.0019 Silverman, 2009, Osteonecrosis of the jaw and the role of bisphosphonates: a critical review, Am J Med, 122, S33, 10.1016/j.amjmed.2008.12.005 Stafford, 2004, National trends in osteoporosis visits and osteoporosis treatment, 1988–2003, Arch Intern Med, 164, 1525, 10.1001/archinte.164.14.1525 Tuby, 2006, Modulations of VEGF and iNOS in the rat heart by low level laser therapy are associated with cardioprotection and enhanced angiogenesis, Lasers Surg Med, 38, 682, 10.1002/lsm.20377 Vescovi, 2006, Bisphosphonate-associated osteonecrosis of the jaw: a possible treatment?, J Oral Maxillofac Surg, 64, 1460, 10.1016/j.joms.2006.05.042 Vescovi, 2008, Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg, 66, 831, 10.1016/j.joms.2007.11.025 Vescovi, 2009, Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT), Lasers Med Sci, 25, 101, 10.1007/s10103-009-0687-y Wessel, 2008, Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case–control study, J Oral Maxillofac Surg, 66, 625, 10.1016/j.joms.2007.11.032 Woo, 2006, Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws, Ann Intern Med, 144, 753, 10.7326/0003-4819-144-10-200605160-00009 Yarom, 2007, Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome, Osteoporos Int, 18, 1363, 10.1007/s00198-007-0384-2